|
Therapeutic oligonucleotides are transforming the treatment of complex diseases, but understanding their metabolism is critical to advancing safe and effective therapies.
This QPS white paper highlights strategies for metabolite identification, profiling, and quantitation that help sponsors navigate development challenges and generate the data needed to support successful drug programs.
|